NDC 75987-058 – Krystexxa
Pegloticase 8 mg/50mL · Injection, Solution · Intravenous
Product NDC75987-058
Product details
- Brand name
- Krystexxa
- Generic name
- Pegloticase
- Labeler
- Horizon Therapeutics USA, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125293
- Marketed since
- August 29, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Uric Acid-specific Enzyme
Active ingredients
- Pegloticase 8 mg/50mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 75987-058-01 | 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL | Aug 29, 2025 |
Other Krystexxa products
- 75987-080 Pegloticase 8 mg/mL · Injection, Solution · Horizon Therapeutics USA, Inc.